What's Happening?
The FDA has exempted tagatose, a low-calorie sweetener, from 'added sugar' labeling requirements on US food labels. This decision follows a campaign by Bonumose, a Virginia-based startup, to change the FDA's stance. Tagatose, which offers health benefits
such as improved glycemic control, was previously classified as 'added sugar,' hindering its adoption by food manufacturers. The exemption is expected to boost tagatose's market presence, with Bonumose planning to scale production significantly. The FDA's decision acknowledges tagatose's lower caloric value and non-cariogenic properties.
Why It's Important?
The FDA's exemption of tagatose from 'added sugar' labeling is significant as it removes a major barrier to its adoption by food manufacturers. This change is likely to increase the use of tagatose in various food products, offering consumers healthier alternatives to traditional sugars. The decision reflects a growing recognition of the benefits of rare sugars in promoting health and wellness. For Bonumose, the exemption provides an opportunity to expand production and capitalize on the increased demand for low-calorie sweeteners, potentially leading to greater market penetration and revenue growth.
